350 related articles for article (PubMed ID: 15617987)
1. Microcompetition and the origin of cancer.
Jariwalla RJ
Eur J Cancer; 2005 Jan; 41(1):15-9. PubMed ID: 15617987
[TBL] [Abstract][Full Text] [Related]
2. How aneuploidy may cause cancer and genetic instability.
Duesberg P; Rasnick D; Li R; Winters L; Rausch C; Hehlmann R
Anticancer Res; 1999; 19(6A):4887-906. PubMed ID: 10697602
[TBL] [Abstract][Full Text] [Related]
3. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
[TBL] [Abstract][Full Text] [Related]
4. [Molecular basis of cancer].
Meza-Junco J; Montaño-Loza A; Aguayo-González A
Rev Invest Clin; 2006; 58(1):56-70. PubMed ID: 16789600
[TBL] [Abstract][Full Text] [Related]
5. Mining for regulatory programs in the cancer transcriptome.
Rhodes DR; Kalyana-Sundaram S; Mahavisno V; Barrette TR; Ghosh D; Chinnaiyan AM
Nat Genet; 2005 Jun; 37(6):579-83. PubMed ID: 15920519
[TBL] [Abstract][Full Text] [Related]
6. [Acquired mutations--basic cancer biology].
Grønbaek K; Guldberg P
Ugeskr Laeger; 2006 Jun; 168(24):2335-8. PubMed ID: 16822414
[TBL] [Abstract][Full Text] [Related]
7. The RAD51 gene family, genetic instability and cancer.
Thacker J
Cancer Lett; 2005 Mar; 219(2):125-35. PubMed ID: 15723711
[TBL] [Abstract][Full Text] [Related]
8. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Thomas S; Reisman D
Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
10. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development.
Capp JP
Bioessays; 2005 Dec; 27(12):1277-85. PubMed ID: 16299757
[TBL] [Abstract][Full Text] [Related]
11. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
Ballestar E; Esteller M
Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
[TBL] [Abstract][Full Text] [Related]
12. Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors.
Morán A; Iniesta P; de Juan C; García-Aranda C; Díaz-López A; Benito M
Cancer Res; 2005 May; 65(9):3811-4. PubMed ID: 15867378
[TBL] [Abstract][Full Text] [Related]
13. Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution.
Campbell I; Polyak K; Haviv I
Cancer Res; 2009 Sep; 69(17):6765-8; discussion 6769. PubMed ID: 19706773
[TBL] [Abstract][Full Text] [Related]
14. A new model for oncogenesis. From tumour immunology to a mathematical approach of oncogenesis.
Den Otter W; Koten JW; Derkinderen DJ
Anticancer Res; 1986; 6(3 Pt B):509-14. PubMed ID: 3740800
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
Spandidos DA
J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
[TBL] [Abstract][Full Text] [Related]
16. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer.
Biedermann K; Vogelsang H; Becker I; Plaschke S; Siewert JR; Höfler H; Keller G
J Pathol; 2005 Oct; 207(2):199-206. PubMed ID: 16025435
[TBL] [Abstract][Full Text] [Related]
17. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
Wynter CV
Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
[TBL] [Abstract][Full Text] [Related]
18. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
Jardin F; Sahota SS
Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
[TBL] [Abstract][Full Text] [Related]
19. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
